510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
MZGClass II

Test, Residual, Wbc In Leukoreduced Blood

21 CFR 864.8625 / Hematology
FDA source (opens on fda.gov)

MZG is the FDA product code for Test, Residual, Wbc In Leukoreduced Blood, a class II device type, regulated under 21 CFR 864.8625. FDA's definition for this code reads: "CBER". As of , FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code
MZG
Device name
Test, Residual, Wbc In Leukoreduced Blood
FDA definition
CBER
Regulation
21 CFR 864.8625
Device class
Class II
Review panel
Hematology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
0
Ingested recalls
0

Companies listing this code with FDA

Companies whose registered establishments list this code